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Abstract
Background: Cesarean scar pregnancy (CSP) is a late serious complication of cesarean section. There has been an
increase in the incidence of CSP worldwide in recent years. It’s a life-threatening condition because of the high risk
of uncontrolled hemorrhage and uterine rupture. The mechanism of CSP is still unclear. The endometrial receptivity
might be different in the cesarean scar between CSP and normal pregnancies. Endometrial expression of integrin
β3 and LIF positively correlates with endometrial receptivity and embryo implantation. The purpose of the study is
to explore the mechanism of CSP.
Methods: The EnVision two-step immunohistochemical staining technique was used to detect the expression of
integrin β3 and LIF in the decidua of women with CSP (20 cases) and normal pregnancies (20 cases). The
distribution and staining intensity of integrin β3 and LIF in the two groups were observed. Observation of the
staining were done using microscope within five randomly selected high-power fields (HPF, 10 × 40). All data
analyses were conducted with SPSS 17.0 and the statistical significance was set at P <0.05.
Results: The decidua in the different parts of both two groups that stained with the anti-integrin β3 and anti-LIF
antibody: most of the integrin β3 and LIF positive cells were located in glandular epithelium. The expression
intensity of integrin β3 in the cesarean scar in CSP group was significant higher than the uterine cavity in CSP
group and the cesarean scar in normal pregnancy group. It’s similar with the uterine cavity in normal pregnancy
group. The expression intensity of LIF in the cesarean scar in CSP group was significant higher than the uterine
cavity in CSP group and the cesarean scar in normal pregnancy group. It’s significant lower than the uterine cavity
in normal pregnancy group.
Conclusions: The decidual integrin β3 and LIF might play an important role in the mechanism of CSP. The
increase expression of integrin β3 and LIF in the cesarean scar decidua might be associated with embryo
implantation in cesarean scar. The occurrence of CSP might be related to the changes of endometrial
receptivity in local cesarean scar.
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Background
A cesarean scar pregnancy (CSP) is defined as a gesta-
tional sac located in the scar of a previous cesarean
section (CS). It is a late serious complication of CS. The
incidence of CSP is between 1:2226 and 1:1800 [1, 2].
CSP is rare. Over the past few years, with the rising rate
of CS all over the world, there has been an increase in
the incidence of CSP worldwide, especially in China [3].
CSP is considered a life-threatening condition because
of the high risk of uncontrolled hemorrhage and uterine
rupture, which might lead to a hysterectomy, with
catastrophic consequences for the patient's reproductive
future [4].
With limited experience and research of CSP, there is
no consensus regarding the mechanism of CSP. The
pathogenesis of CSP has not been clarified exactly yet.
Embryo implantation is an important step of the re-
productive process, and is critical to CSP. CSP is associ-
ated with embryo implantation in abnormal position
(cesarean scar). Abnormalities in molecular factors of
implantation and many other factors could be correlated
to CSP. The most probable mechanism through which
this can occur is invasion of the myometrium through a
microscopic tract [5]. The tract is believed to develop
from trauma from previous uterine surgeries like CS,
dilatation and curettage and myomectomy. According to
an earlier report, scar dehiscence was observed in 6%-
10% of the women with a history of CS, which is a much
higher rate than the incidence of CSP [6]. Cases have
been reported of a healthy pregnancy occurring after
CSP [7], and disruption of a cesarean scar does not
necessarily lead to the development of repeated CSP.
Previous studies have shown that endometrial expres-
sion of integrin β3 subunit and LIF positively correlates
with endometrial receptivity and embryo implantation
[8]. Both integrin β3 subunit and LIF appeared in the
endometrium coinciding with the window of implant-
ation (WOI) and might be used as markers of endomet-
rial receptivity.
The integrin β3 acts as an adhesion promoter via cell-
cell interactions and it has been very well characterized
within the human endometrium [9]. It is expressed in
the glandular epithelium during the WOI, if pregnancy
occurs [10]. Expression of integrin β3 is a biological
marker for good endometrial receptivity and it plays a
crucial role in blastocyst implantation [11]. Reduced
expression of integrinβ3 has been related to unexplained
infertility. Chen et al. [12] found that integrin β3 partici-
pated in ectopic implantation and might play a key role
in tubal pregnancy.
LIF is a pleiotropic cytokine of the interleukin-6
family, which might play an important role in human
reproduction [13]. It was initially identified by its ability
to induce the macrophage differentiation of the myeloid
leukaemic cell line M1 [14]. As one of the most im-
portant cytokines to influence endometrial receptivity
during the early implantation window, LIF is involved
in the regulation of implantation. In the absence of
LIF, the mouse embryo can develop normally only to
the blastocyst stage [15]. LIF plays a critical role in
implantation in women [16]. Previous study showed
that endometrial cell cultures from infertile women
with repeated abortions or unexplained primary in-
fertility were significantly lower when compared to
fertile women [17].
LIF might contribute to the development of ectopic
pregnancies. Immunohistochemical labeling of LIF in
the fallopian tube was found to be increased in ectopic
pregnancies compared to non-pregnant and healthy
pregnant controls. This might indicate a role of LIF in
the ectopic implantation of embryos [18]. LIF might
facilitate the development of ectopic pregnancy by stimu-
lating blastocyst adhesion and trophoblast outgrowth from
placental explants [19].
Integrin β3 and LIF are the two cellular factors which
have been largely accepted as the promising candidates
of biomarkers of uterine receptivity in human. They are
known to relate to tubal pregnancy. However, It is not
clear whether the blastocyst requires expression of integ-
rin β3 or LIF for implantation into cesarean scar other
than cavity endometrium; such as in CSP. They might
be used to evaluate the change of endometrial receptivity
in cesarean scar in CSP patients.
We assumed that: The endometrial receptivity might
be different in the cesarean scar between CSP and
normal early intrauterine pregnancies. The change of
local endometrial receptivity in the cesarean scar might
be beneficial to the embryo implantation in CSP pa-
tients. We carried out an immunohistochemical research
on the expression of decidual integrin β3 and LIF in
women with CSP. This study aimed to: (a) test whether
integrin β3 and LIF are localized in cesarean scar de-
cidua in CSP patients; (b) investigate whether decidual
integrin β3 and LIF in CSP patients are different from
that of healthy controls; and (c) explore the change of
endometrial receptivity in the mechanism of CSP.
Methods
The diagnosis standard of CSP
The CSP was diagnosed using the following criteria: a
history of CS in the lower uterine segment, positive
serum beta-human chorionic gonadotropin (β-HCG)
level, and fulfillment of the following ultrasonography
standard [20] (Fig. 1): (a) an empty uterine cavity and
cervical canal; (b) development of the gestational sac in
the anterior portion of the lower uterine segment; and
(c) absence of healthy myometrium between the bladder
and the gestational sac.
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Subjects
This is an immunohistochemical study of integrin β3 and
LIF in the uterine decidua. The specimens (the decidua
from cesarean scar and uterine cavity) were obtained from
the Department of Obstetrics and Gynecology, Women’s
Hospital, School of Medicine, Zhejiang University, China,
between October 2013 and September 2014. This hospital
is the largest obstetrics and gynecology medical treatment
center in Zhejiang Province. Samples of CSP group (group
A, 20 cases) were collected from women with CSP by ultra-
sound (LOGIQ P6, GE, USA) guided curettage. Samples of
the normal pregnancy group (group B, 20 cases) were
collected from women who underwent termination of nor-
mal early pregnancies with CS history in the same hospital.
Each case (both CSP and normal pregnancy with cesarean
scar patients) contains two samples of decidua in the differ-
ent position: the cesarean scar and the uterine cavity. All
women were from 20 to 40 years of age with gestation of
less than 10 weeks. Exclusion criteria included inevitable
abortion, missed abortion, incomplete abortion, cervical
pregnancy, genetic, endocrine and immune disorders, can-
cer, genital anatomical abnormalities and major surgical
diseases, history of long-term medication, trophoblastic
disease, those undergoing endocrine therapy, chemother-
apy, and radiotherapy, and significant maternal cardiac,
renal, hepatic, and blood system disease. Written informed
consent for the surgery and participation was obtained
from each patient in the study, and the protocol was
approved by the Institutional Review Board in Women’s
Hospital, School of Medicine, Zhejiang University.
Immunohistochemistry
Decidual samples were immediately placed into a 10%
formaldehyde solution bag and fixed for 10 to 24 h.
Paraffin blocks were sectioned into a 4 μm thickness.
The EnVision two-step immunohistochemical staining
technique was used to detect the expression of integrin
β3 and LIF in the decidua in the different parts. The
immunohistochemical staining was done by one person
only. Positive controls were included in every batch of
tests. Primary antibodies: Rabbit antihuman integrin β3
(clone number EPR2417Y) was obtained from Abcam
Biotechnology Co., Ltd, USA. Mouse antihuman LIF
(clone number IMG39N7D10) was obtained from Abcam
Biotechnology Co., Ltd, USA. The secondary antibody
used was ChemMatei Envisioni Detection Kit Peroxidase/
DAB, from DAKO Biotechnology Co., Ltd, Denmark. The
human normal tonsil tissue was used as an integrin β3
positive control, and the mouse colon tissue was used as a
LIF positive control.
Positive cells displayed brown membrane and cyto-
plasmic staining features. The distribution and quantity
of two markers in the two groups were observed. Semi-
quantitative analysis was done by staining intensity
observation using microscope within five randomly se-
lected high-power fields (HPF, 10 × 40). All the immu-
nostained slides were reviewed by two observers
independently. Observation of the staining was done
using an Olympus CHK microscope (Olympus, Japan).
Staining intensity of tissue sections was evaluated and
graded (0, absence; 1, weak; 2, moderate; 3, strong). It
was assessed by calculating the total score of five HPF.
Photomicrographs were taken using a digital camera
(Nikon, Japan).
Statistics
The general information of the two groups was eva-
luated. The difference in the expression intensity of
decidual integrin β3 and LIF in the cesarean scar and
uterine cavity between the two groups was evaluated.
All data analyses were conducted with SPSS 17.0
(SPSS Inc., USA). A two-tailed significance test was
used for all comparisons, and statistical significance
was set at P < 0.05. Data were analyzed for normal
distribution with the Kolmogorov-Smirnov test and
for homogeneity of variance with the Levene test. If
variables met assumptions of normality and homogen-
eity of variance, an independent samples t test was
used. If not, a nonparametric test (the Mann-Whitney
U test) was used.
Results
A total of 40 patients were enrolled in the study. His-
topathologic examination performed on tissue ob-
tained at surgery confirmed the diagnosis of CSP and
normal early pregnancies. There were no significant
differences of the baseline parameters of subjects in
the two groups (Table 1).
Fig. 1 A cesarean scar pregnancy demonstrated by ultrasound
showing the gestational sac implanted in the lower segment
dehiscence of the anterior myometrium. The residual myometrium
was thin and the amniotic sac bulged into the uterovesical fold
under the cesarean scar (indicated by the arrow). CX: cervix; F:
fundal endometrial cavity
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The location of decidual integrin β3
The decidua in the different parts of both two groups
stained with the anti-integrin β3 antibody: most of the
integrin β3 positive cells in the decidua from the two
groups were located in maternal uterine epithelium and
glandular epithelium (membrane and cytoplasm stain-
ing) and very few of these cells were present at very
weak staining in the stroma (Fig. 2).
The staining intensity of decidual integrin β3
The staining intensity of decidual integrin β3 in the
cesarean scar in CSP group was 13.35 ± 1.18/5HPF:
significant higher than the uterine cavity in CSP group
(9.90 ± 2.10/5HPF, t = 6.402, p =0.000); significant higher
than the cesarean scar in normal pregnancy group
(8.10 ± 1.71/5HPF, t = 11.278, p =0.000); similar with
the uterine cavity in normal pregnancy group (13.45 ±
1.05/5HPF, t = −0.283, p =0.779).
The location of decidual LIF
The decidua in the different parts of both two groups
was also positive for LIF: most of the LIF positive cells
in the decidua from the two groups were located in ma-
ternal uterine epithelium and glandular epithelium
(membrane and cytoplasm staining) and some of these
cells were present at weak staining in the stroma (Fig. 3).
The staining intensity of decidual LIF
The staining intensity of decidual LIF in the cesarean
scar in CSP group was 7.75 ± 1.80/5HPF: significant
Table 1 Patient characteristics and demographics
Characteristic Group A (n = 20) Group B (n = 20) P value
Maternal age (years) 33.80 ± 4.70 31.50 ± 3.98 0.103a
Abortion (times) 2.05 ± 1.64 1.30 ± 1.03 0.091a
Gestational age (days) 45.00 ± 5.73 47.45 ± 7.12 0.238a
Gestational sac diameter (cm) 2.30 ± 0.84 2.27 ± 0.77 0.907a
Number of prior CS [times, median (range)] 1 (1–2) 1 (1–2) 0.602b
Interval between CS and CSP (months) 64.50 ± 53.27 50.35 ± 30.16 0.308a
Normal distribution (mean ± SD), non-normal distribution [median (range)]. Unless noted otherwise, values are presented as mean ± SD
P values for specific categories refer to differences present among the categories
CS cesarean section, CSP cesarean scar pregnancy
aP value is from independent samples t test
bP value is from Mann-Whitney test
Fig. 2 Representative pictures of immunohistochemical expression of decidual integrin β3 subunit in cesarean scar and uterine cavity in the two
groups. a CSP-cesarean scar decidua (A strong positive immunohistochemical staining in glandular epithelial cells, 10 × 20); b CSP-uterine cavity
decidua (A medium positive immunohistochemical staining in glandular epithelial cells, 10 × 20); c Normal early pregnancy-cesarean scar decidua
(A medium positive immunohistochemical staining in glandular epithelial cells, 10 × 20); d Normal early pregnancy-uterine cavity decidua (A strong
positive immunohistochemical staining in glandular epithelial cells, 10 × 20)
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higher than the uterine cavity in CSP group (5.25 ± 0.55/
5HPF, t = 5.932, p =0.000); significant higher than the
cesarean scar decidua in normal pregnancy group (6.65 ±
1.50/5HPF, t = 2.100, p =0.042); significant lower than the
uterine cavity in normal pregnancy group (10.00 ± 1.97/
5HPF, t = −3.746, p =0.001).
Discussion
CSP is an infrequent type of ectopic pregnancy. It carries
a high risk of uterine rupture and uncontrollable bleed-
ing. It is important to maintain a high index of clinical
suspicion. The etiology of cesarean scar implantation is
still far from complete, but the bulk of the existing
literature supports the hypothesis that it arises from a
combination of cesarean scar disruption (the trauma
theory), cytokines and enzymes changes in the cesarean
scar environment. However, with limited research, the
precise mechanism of CSP is unknown, factors critical
for embryo implantation into the uterus might also con-
tribute to blastocyst implantation in the cesarean scar.
For implantation to occur, the blastocyst must first
lose the zona pellucida to allow intimate adhesion
between the trophectoderm and the uterine epithelial
surface. A WOI has also been proposed to occur in the
cesarean scar, during which time the cesarean scar
epithelium is susceptible to ectopic implantation. The
change of local endometrial receptivity in the cesarean
scar might be beneficial to the embryo implantation in
CSP patients. Therefore, immunohistochemical labeling
of integrin β3 and LIF in the cesarean scar and uterine
cavity region from women with CSP and intrauterine
pregnancy were studied in this research.
This investigation revealed that the decidua in the
different parts of both two groups were positive for
integrin β3. Most of the integrin β3 positive cells in the
decidua were located in maternal uterine epithelium and
glandular epithelium. The expression of integrin β3
showed statistically significant differences in different
parts between the two groups. Integrin β3 expression in
cesarean scar decidua was statistically significantly in-
creased in women with CSP compared to normal early
pregnant women. It demonstrates that the increase
expression of integrin β3 in the cesarean scar decidua
might be associated with embryo implantation in cesarean
scar, which might lead to CSP.
Our results are similar with Chen et al. [12]. They
found that expression of integrin β3 in tubal epithelium
of tubal pregnancy was higher than that in normal tubal
epithelium, but lower than that in normal decidual cells.
Integrin β3 might play a role in ectopic pregnancy. A
previous study revealed that high levels of integrin β3
expression correlate with the appearance of pinopodes
on postovulatory days 7 to 8 [21], which provides a char-
acteristic biomarker for endometrial receptivity during
the early implantation window phase [10]. Other authors
found that a reduction of integrin β3 during the implant-
ation window in patients with recurrent pregnancy loss,
compared to controls, either in frozen sections [22, 23].
Fig. 3 Representative pictures of immunohistochemical expression of LIF in cesarean scar decidua and uterine cavity decidua in the two groups.
a CSP-cesarean scar decidua (A medium positive immunohistochemical staining, primarily in glandular epithelial cells, 10 × 20); b CSP-uterine
cavity decidua (A weak positive immunohistochemical staining, primarily in glandular epithelial cells, 10 × 20); c Normal early pregnancy-cesarean scar
decidua (A weak positive immunohistochemical staining, primarily in glandular epithelial cells, 10 × 20); d Normal early pregnancy-uterine cavity
decidua (A medium positive immunohistochemical staining, primarily in glandular epithelial cells, 10 × 20)
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Endometrium is composed of various cells and the
extracellular matrix composition (ECM), containing
abundant integrin. To implant, the blastocyst needs to
aggressively adhere to the endometrium so that it can be
provided with oxygen and nutrients. It is necessary to
have a receptive endometrium that allows the invasion
of the blastocyst and the rapid growth of the placenta
while supporting the transformation of uterine into de-
cidual cells. The important role of integrin in embryo
implantation is gradually recognized. The integrins are a
family of widely expressed heterodimeric cell surface
receptors that mediate cell-cell and ECM adhesion. In
addition to providing a physical transmembrane link
between the extracellular environment and the cytos-
keleton, they are capable of transducing bi-directional
signals across the cell membrane [24]. ECM-integrin-
cytoskeleton complex is the basic structure of integrin
signaling pathway. Integrin-mediated signaling pathways
play very important roles in embryo implantation, in-
cluding focal adhesion kinase (FAK), protein kinase B
(PKB) and extracellular signal-regulated protein kinase
(ERK) [25, 26]. Kabir-Salmani et al. indicated that integ-
rin β3 localization in the core of focal adhesions of
extravillous trophoblast cells and that integrin β3 signal-
ing pathways are activated in insulin-like growth factor-I
(IGF-I)-mediated migration of these cells [27].
We consider that the maternal glandular epithelium
and uterine epithelium are close to gestational sac (the
maternal-fetal interface). Integrin β3 and other cytokines
might be involved in gathering the local response in the
cesarean scar decidua during the embryo implantation.
The decidual integrin β3 might play an important role in
the mechanism of CSP. CS causes the injury of myome-
trium and basal layer of the endometrium. The forma-
tion of scar tissue and fibrosis is in response to CS
damage. There might be some postoperative complica-
tions that affect uterine incision healing. Then, a micro-
scopic tract is believed to develop from the trauma of
previous CS. After a CS, women could attempt another
pregnancy. Receptivity of endometrium is influenced
by many factors, and it is not benefit embryo implant-
ation. Integrin on trophoblast is combined with ligand
on cesarean scar endometrium, which facilitating em-
bryo recognition and attachment. The embryo is ectopic
implanted in the cesarean scar and eventually lead to the
occurrence of CSP.
This investigation revealed that the decidua in the
different parts of both two groups were positive for LIF.
Most of the LIF positive cells in the decidua were
located in maternal uterine epithelium and glandular
epithelium. The expression of LIF showed statistically
significant differences in different parts between the two
groups. LIF expression in cesarean scar decidua was
statistically significantly increased in women with CSP
compared to normal early pregnant women. It suggests
that the increase expression of LIF in the cesarean scar
decidua might be associated with embryo implant in
cesarean scar, which might lead to CSP.
A previous study revealed that LIF expression in the
fallopian tube was found to be increased in ectopic preg-
nancies compared to non-pregnant and healthy pregnant
controls [18]. Our results are similar with it. LIF might
contribute to the development of ectopic pregnancies by
facilitating the development of ectopic pregnancy by
stimulating blastocyst adhesion and trophoblast out-
growth from placental explants [19].
LIF is essential for embryo implantation. LIF regulates
trophoblast function and vascular formation in the pla-
centa. It is essential for embryo implantation in the
endometrium. The expression of LIF has been demon-
strated in the uterus of a variety of mammals. In most
species, endometrial LIF expression increases around the
time of blastocyst implantation. The expression of LIF
and its receptor (LIFR) in human endometrium reaches
peak levels during the peri-implantation phase [28]. In
many species, LIF remains raising throughout the posto-
vulatory phase and this might reflect a need for this
cytokine throughout prei-implantation blastocyst devel-
opment. LIF expression is also elevated during early
pregnancy in many species investigated.
LIF is a secreted glycoprotein that signals via the
gp130/LIFR complex to activate the Janus tyrosine
kinases (JAK). This, in turn, can activate downstream
signaling pathways, including the signal transducer and
activator of transcription (STAT) pathway [29], or extra-
cellular signal regulated kinase (ERK) [30]. In the human
endometrium and trophoblast, LIF primarily acts via
STAT3 [31]. LIF is also involved in regulating the
balance between type 1 T-helper (Th1) and type 2 T-
helper (Th2), and the Th1/Th2 balance regulates the
maintenance of the pregnancy [32]. A shift from Th1 to
Th2 response at the maternal-fetal interface may con-
tribute to successful pregnancy [33].
When women with a microscopic tract developped
from previous CS attempt another pregnancy, LIFR on
trophoblast is combined with LIF on cesarean scar en-
dometrium, which facilitating embryo recognition and
attachment. LIF might stimulate blastocyst adhesion and
trophoblast outgrowth from placental explants. Then,
the embryo is ectopic implanted in the cesarean scar
and eventually lead to the occurrence of CSP.
There are a few weaknesses in this study. For example,
some limitations of this study due to the small sample
size and semi-quantitative evaluation observed. It is also
possible that the different staining intensity of integrin
β3 and LIF might represent a local response to the preg-
nancy, rather than a cause of ectopic pregnancy. Previ-
ous reports have verified a cycle-dependent expression
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of the integrin β3 and LIF in the human endometrium
[10, 28]. The expression of decidual integrin β3 and LIF
in early pregnancy stages might be different from WOI.
However, CSP is a rare type of ectopic pregnancy. The oc-
currence of CSP is very difficult to predict. We could not
obtain the specimens around the implantation window in
CSP patients. So we collected and studied the decidua in
early pregnancy stages, to speculate the changes of endo-
metrial receptivity during the implantation window.
Conclusions
The etiology of CSP remains unknown in spite of an
increasing interest. In CSP, embryo implantation is an
extremely complex physiological process regulated by
many factors in the uterus and embryo, and the under-
lying mechanism has not yet been fully elucidated. Using
immunohistochemical analysis, we found that integrin
β3 subunit and LIF were expressed in the decidua of
CSP patients and normal pregnant women. There were
significant differences in the staining intensity of decid-
ual integrin β3 subunit and LIF between CSP group and
the control group during the early pregnancies. Our
results indicated that: (a) the decidual integrin β3 and
LIF might play an important role in the mechanism of
CSP; (b) the increase expression of decidual integrin β3
and LIF in the cesarean scar might be associated with
embryo implantation in cesarean scar, which might lead
to a CSP; and (c) the occurrence of CSP might be related
to the changes of endometrial receptivity in local cesarean
scar. However, embryo implantation is affected by both
the embryo and endometrium in CSP patients. Consider-
ing the rising incidence of CSP and its catastrophic conse-
quences, further studies are needed. Despite awareness of
the limitations of this study, the results encourage further
larger studies in this promising research field.
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